2 mg semaglutide to tirzepatide GLP-Squared Injection | Starts at $249/mo Switching from Semaglutide to Tirzepatide:

The Clinical Evidence Animal Studies (Compelling Foundation) Multiple animal studies have shown dramatic results: Rat tendon repair (2015 study): BPC-157 treated group: 87% functional recovery by day 14 Control group: 42% functional recovery by day 14 Treated tendons showed superior collagen organization and strength Rat ACL studies: BPC-157 accelerated cruciate ligament healing Improved biomechanical properties of healed tissue Enhanced recovery of motor function Systemic benefits: Improved gastric ulcer healing (origin research) Accelerated bone fracture healing Enhanced wound healing Human Clinical Data (Emerging) While human long-term trials are still limited, preliminary human studies show: Chronic tendinopathy cases: Improvements in pain and function Better ultrasound imaging of tendon structure Return to activity timelines shortened by 30-50% in pilot studies Post-surgical recovery: Athletes returning to training faster Reduced post-operative pain Better functional outcomes in ACL reconstructions (preliminary data) Safety profile: No serious adverse events in human trials to date Well-tolerated across multiple routes of administration No apparent systemic toxicity Important caveat : Human clinical research on BPC-157 is still in early stages

King CD, Rios GR, Green MD, Tephly TR

Some studies show that psyllium husk use could actually reduce your risk of some types of cancer, like colon cancer and breast cancer

But if swallowed, methylene blue can turn your urine and stool green until its out of your system

NAD IV therapy, B12 shots, and fat-burning injections are not the same as semaglutide or tirzepatide